Skip to main content

Advertisement

SpringerLink
Log in

Aptamers: a novel class of radiopharmaceutical with diagnostic and therapeutic potential

  • Editorial
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lister-James J, Moyer BR, Dean T. Small peptides radiolabeled with 99mTc. Q J Nucl Med 1996; 40:221–233.

    CAS  PubMed  Google Scholar 

  2. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346:818–822.

    Article  CAS  PubMed  Google Scholar 

  3. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249:505–510.

    CAS  PubMed  Google Scholar 

  4. Famulok M, Mayer G. Aptamers as tools in molecular biology and immunology. Curr Top Microbiol Immunol 1999; 243:123–136.

    CAS  PubMed  Google Scholar 

  5. Brody EN, Gold L. Aptamers as therapeutic and diagnostic agents. J Biotechnol 2000; 74:5–13.

    Article  CAS  PubMed  Google Scholar 

  6. Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson-Welsh L, Janjic N. 2'-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 1998; 273:20556–20567.

    Article  CAS  PubMed  Google Scholar 

  7. Hicke BJ, Stephens AW. Escort aptamers: a delivery service for diagnosis and therapy. J Clin Invest 2000; 106:923–928.

    CAS  PubMed  Google Scholar 

  8. Hjelstuen OK, Saetern AM, Tonnesen HH, Bremer PO, Verbruggen AM. Development of a lyophilized kit formulation for labeling of DNA probes with99mTc. Int J Pharm 1999; 190:197–205.

    Article  CAS  PubMed  Google Scholar 

  9. Hnatowich DJ. Antisense imaging: where are we now? Cancer Biother Radiopharm 2000; 15:447–457.

    CAS  PubMed  Google Scholar 

  10. Dougan H, Hobbs JB, Weitz JI, Lyster DM. Synthesis and radioiodination of a stannyl oligodeoxyribonucleotide. Nucleic Acids Res 1997; 25:2897–2901.

    Article  CAS  PubMed  Google Scholar 

  11. Kuhnast B, Dolle F, Terrazzino S, Rousseau B, Loc'h C, Vaufrey F, Hinnen F, Doignon I, Pillon F, David C, Crouzel C, Tavitian B. General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. Bioconjug Chem 2000; 11:627–636.

    Article  CAS  PubMed  Google Scholar 

  12. Charlton J, Sennello J, Smith D. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chem Biol 1997; 4:809–816.

    CAS  PubMed  Google Scholar 

  13. Buckanovich RJ, Darnell RB. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol Cell Biol 1997; 17:3194–3201.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Biology, University of Bonn, Germany

    S. Guhlke & H. J. Biersack

  2. Kekulé Institute of Organic Chemistry and Biochemistry, University of Bonn, Gerhard-Domagk Strasse 1, 53121, Bonn, Germany

    M. Famulok

Authors
  1. S. Guhlke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Famulok
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. J. Biersack
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Famulok.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guhlke, S., Famulok, M. & Biersack, H.J. Aptamers: a novel class of radiopharmaceutical with diagnostic and therapeutic potential. Eur J Nucl Med Mol Imaging 30, 1441–1443 (2003). https://doi.org/10.1007/s00259-003-1346-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-003-1346-3

Search

Navigation